Welcome to consult Elem's high-throughput CRISPR service.

86-180-6253-9203

services@elem-bio.com

Contact us to order

TREM2 Knockout RBE Cell Pool

Hot Products

undefined
undefined
+
  • undefined
  • undefined

Number:

LM01085095970

Product ID: LM01085095970

Market price

Selling Price:  ¥ 5499

Quantity
-
+

Stock surplus

0

Contact us to order

Antibody custom service consulting

隐藏域元素占位

  • 产品描述
  • 细胞复苏
  • 细胞传代
  • 细胞冻存
  • 抗体验证结果
    • Brand: ELEM粒曼
    • Commodity name: TREM2 Knockout RBE Cell Pool
    • Commodity ID: LM01085095970
    • Gene Symbol: TREM2
    • Ensembl ID: ENSG00000095970
    • Uniprot ID: Q9NZC2
    • 宿主细胞 / 类型: RBE/human hepatobiliary carcinoma cells
    • NCBI Gene ID: 54209
    • 规格: 1×10^6 cells/frozen vial
    • 生长培养基: 89% 1640 + 10% FBS + 1% double antibody
    • 筛选标记: N/A
    • 生长特性: Adherent cells, epithelial-like
    • 培养条件: Incubator at 37°C with 5% CO2; passage at 1/2 to 1/4 confluence.
    • 倍增时间: ~24-36 hours
    • 参考换液频率: 2–3 times per week
    • 支原体检测结果: Negative
    • 敲除效率(Sanger测序): 95%
    • 蛋白质组验证结果: N/A
    • 抗体货号: Adding...
    • 目标基因介绍: Forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia (PubMed:27477018, PubMed:29518356). Binding to amyloid-beta 42 mediates microglial activation, proliferation, migration, apoptosis and expression of pro-inflammatory cytokines, such as IL6R and CCL3, and the anti-inflammatory cytokine ARG1 (By similarity). Acts as a receptor for lipoprotein particles such as LDL, VLDL, and HDL and for apolipoproteins such as APOA1, APOA2, APOB, APOE, APOE2, APOE3, APOE4, and CLU and enhances their uptake in microglia (PubMed:27477018). Binds phospholipids (preferably anionic lipids) such as phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol and sphingomyelin (PubMed:29794134). Regulates microglial proliferation by acting as an upstream regulator of the Wnt/beta-catenin signaling cascade (By similarity). Required for microglial phagocytosis of apoptotic neurons (PubMed:24990881). Also required for microglial activation and phagocytosis of myelin debris after neuronal injury and of neuronal synapses during synapse elimination in the developing brain (By similarity). Regulates microglial chemotaxis and process outgrowth, and also the microglial response to oxidative stress and lipopolysaccharide (By similarity). It suppresses PI3K and NF-kappa-B signaling in response to lipopolysaccharide; thus promoting phagocytosis, suppressing pro-inflammatory cytokine and nitric oxide production, inhibiting apoptosis and increasing expression of IL10 and TGFB (By similarity). During oxidative stress, it promotes anti-apoptotic NF-kappa-B signaling and ERK signaling (By similarity). Plays a role in microglial MTOR activation and metabolism (By similarity). Regulates age-related changes in microglial numbers (PubMed:29752066). Triggers activation of the immune responses in macrophages and dendritic cells (PubMed:10799849). Mediates cytokine-induced formation of multinucleated giant cells which are formed by the fusion of macrophages (By similarity). In dendritic cells, it mediates up-regulation of chemokine receptor CCR7 and dendritic cell maturation and survival (PubMed:11602640). Involved in the positive regulation of osteoclast differentiation (PubMed:12925681).
    • 细胞开发路径: A stable KO cell pool was generated using the CRISPR‑RNP approach; Sanger sequencing revealed a knockout efficiency of 95% in the cell pool.
    • 应用: A gene knockout cell pool with high knockout efficiency (KO Cell Pool) is particularly well suited for preliminary functional analyses, the development of complex disease models, precision drug screening, and broad‑scale gene discovery studies. The KO pool can be directly applied to a variety of assays and analyses without the need for time‑consuming single‑clone selection, significantly enhancing experimental throughput.
    Key words:
    • TREM2
  • 01. Preheat the complete culture medium in a 37°C water bath.
    02. Thaw the cryovial in a 37°C water bath for 1–2 minutes.
    03. Transfer the cryovials into a biosafety cabinet and wipe their surfaces with 70% ethanol.
    04. Unscrew the cap of the cryovial and gently transfer the cell suspension into a sterile centrifuge tube containing 9 mL of complete culture medium.
    05. Centrifuge at room temperature at 125g for 5–7 minutes, then discard the supernatant.
    06. Resuspend the cell pellet in 5 mL of complete culture medium, and transfer the cell suspension to a T25 culture flask.
    07. Transfer the cells to a 37°C incubator with 5% CO2 for culture.
    08. Recommended passage ratio: 1/2 to 1/4; cells reach confluence in 2–3 days.

  • 01. When the cells in the culture flask reach a confluence of 80%–90% or higher, cell passage can be performed.
    02. Remove the culture medium, PBS, and trypsin (0.25% Trypsin‑EDTA, Gibco 25200‑056) from the 4°C refrigerator, place them in a 37°C water bath, and once their temperature approaches 37°C, take them out. Spray the exterior of the bottles with 75% ethanol, then transfer them to a biosafety cabinet.

    03. Remove the culture flask to be passaged from the incubator, spray the exterior of the flask with 75% ethanol, and place it inside a biosafety cabinet.
    04. To avoid dispersing the cells, gently rinse the cells along the inner wall of the culture flask with PBS; discard the wash solution, and add 2 mL of PBS to the T25 flask.
    05. Add the appropriate volume of trypsin (1.5 mL for a T75 flask, 0.5 mL for a T25 flask), and gently swirl the flask to ensure the enzyme evenly covers the cell‑free surface. Adjust the volume as needed based on the specific conditions. After approximately 1–2 minutes, when most of the cells have detached, add the corresponding volume of complete culture medium to stop the digestion, then use a 5‑mL pipette to gently pipette up and down until all cells are fully detached.
    06. Transfer the cell suspension to a 15 mL centrifuge tube, centrifuge at 300 × g for 5 minutes, and discard the supernatant.
    07. Transfer 5 mL of complete culture medium to resuspend the cells, adjust the seeding ratio as needed, and replenish the culture flask with complete medium—add up to 13–15 mL for a T75 flask or 5 mL for a T25 flask—and supplement with 1% double antibiotic solution.
    08. After capping the bottle and tightening the lid, gently shake the vial to ensure uniform mixing of the cells, then place it in a 37°C incubator with 5% CO2.

  • 01. Prepare the cryopreservation solution and pre-cool it in advance.
    02. Ensure that the cells to be cryopreserved meet the cryopreservation requirements, and verify the following conditions under a microscope: healthy appearance and morphological characteristics, being in the late logarithmic growth phase, and showing no signs of contamination or senescence.
    03. Digest and centrifuge the cells (refer to the subculture protocol for specific steps).
    04. Resuspend the cells in cryopreservation medium at 1 mL per tube, gently pipette up and down to ensure uniformity, then aliquot into cryovials.
    05. Place the cells in a programmed cooling box and freeze them in a −80°C freezer.
    06. Subsequently, the cells are transferred to a liquid nitrogen tank for long-term storage.

  • In antibody validation

Classification: Gene Knockout Cell Pool(KO Pool)

Cell Line Information

Gene Symbol

TREM2

NCBI Gene ID

54209

Ensembl ID

ENSG00000095970

Uniprot ID

Q9NZC2

Screening marker

N/A

Host cell/type

RBE/human hepatobiliary carcinoma cells

Specifications

1×10^6 cells/frozen vial

Growth Medium

89% 1640 + 10% FBS + 1% double antibody

growth characteristics

Adherent cells, epithelial-like

culture condition

Incubator at 37°C with 5% CO2; passage at 1/2 to 1/4 confluence.

doubling time

~24-36 hours

Reference fluid change frequency

2–3 times per week

Mycoplasma test results

Negative

Knock-out validation

Knockout efficiency (Sanger sequencing)

95%

Proteome Validation Results

N/A

Antibody number

Adding...

Antibody validation results

In antibody validation

Cell Line Description

Introduction of target gene

Forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia (PubMed:27477018, PubMed:29518356). Binding to amyloid-beta 42 mediates microglial activation, proliferation, migration, apoptosis and expression of pro-inflammatory cytokines, such as IL6R and CCL3, and the anti-inflammatory cytokine ARG1 (By similarity). Acts as a receptor for lipoprotein particles such as LDL, VLDL, and HDL and for apolipoproteins such as APOA1, APOA2, APOB, APOE, APOE2, APOE3, APOE4, and CLU and enhances their uptake in microglia (PubMed:27477018). Binds phospholipids (preferably anionic lipids) such as phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol and sphingomyelin (PubMed:29794134). Regulates microglial proliferation by acting as an upstream regulator of the Wnt/beta-catenin signaling cascade (By similarity). Required for microglial phagocytosis of apoptotic neurons (PubMed:24990881). Also required for microglial activation and phagocytosis of myelin debris after neuronal injury and of neuronal synapses during synapse elimination in the developing brain (By similarity). Regulates microglial chemotaxis and process outgrowth, and also the microglial response to oxidative stress and lipopolysaccharide (By similarity). It suppresses PI3K and NF-kappa-B signaling in response to lipopolysaccharide; thus promoting phagocytosis, suppressing pro-inflammatory cytokine and nitric oxide production, inhibiting apoptosis and increasing expression of IL10 and TGFB (By similarity). During oxidative stress, it promotes anti-apoptotic NF-kappa-B signaling and ERK signaling (By similarity). Plays a role in microglial MTOR activation and metabolism (By similarity). Regulates age-related changes in microglial numbers (PubMed:29752066). Triggers activation of the immune responses in macrophages and dendritic cells (PubMed:10799849). Mediates cytokine-induced formation of multinucleated giant cells which are formed by the fusion of macrophages (By similarity). In dendritic cells, it mediates up-regulation of chemokine receptor CCR7 and dendritic cell maturation and survival (PubMed:11602640). Involved in the positive regulation of osteoclast differentiation (PubMed:12925681).

Cell development path

A stable KO cell pool was generated using the CRISPR‑RNP approach; Sanger sequencing revealed a knockout efficiency of 95% in the cell pool.

Application

A gene knockout cell pool with high knockout efficiency (KO Cell Pool) is particularly well suited for preliminary functional analyses, the development of complex disease models, precision drug screening, and broad‑scale gene discovery studies. The KO pool can be directly applied to a variety of assays and analyses without the need for time‑consuming single‑clone selection, significantly enhancing experimental throughput.

Cell Culture Instructions

Cell Resuscitation

01. Preheat the complete culture medium in a 37°C water bath.
02. Thaw the cryovial in a 37°C water bath for 1–2 minutes.
03. Transfer the cryovials into a biosafety cabinet and wipe their surfaces with 70% ethanol.
04. Unscrew the cap of the cryovial and gently transfer the cell suspension into a sterile centrifuge tube containing 9 mL of complete culture medium.
05. Centrifuge at room temperature at 125g for 5–7 minutes, then discard the supernatant.
06. Resuspend the cell pellet in 5 mL of complete culture medium, and transfer the cell suspension to a T25 culture flask.
07. Transfer the cells to a 37°C incubator with 5% CO2 for culture.
08. Recommended passage ratio: 1/2 to 1/4; cells reach confluence in 2–3 days.

cell passage

01. When the cells in the culture flask reach a confluence of 80%–90% or higher, cell passage can be performed.
02. Remove the culture medium, PBS, and trypsin (0.25% Trypsin‑EDTA, Gibco 25200‑056) from the 4°C refrigerator, place them in a 37°C water bath, and once their temperature approaches 37°C, take them out. Spray the exterior of the bottles with 75% ethanol, then transfer them to a biosafety cabinet.

03. Remove the culture flask to be passaged from the incubator, spray the exterior of the flask with 75% ethanol, and place it inside a biosafety cabinet.
04. To avoid dispersing the cells, gently rinse the cells along the inner wall of the culture flask with PBS; discard the wash solution, and add 2 mL of PBS to the T25 flask.
05. Add the appropriate volume of trypsin (1.5 mL for a T75 flask, 0.5 mL for a T25 flask), and gently swirl the flask to ensure the enzyme evenly covers the cell‑free surface. Adjust the volume as needed based on the specific conditions. After approximately 1–2 minutes, when most of the cells have detached, add the corresponding volume of complete culture medium to stop the digestion, then use a 5‑mL pipette to gently pipette up and down until all cells are fully detached.
06. Transfer the cell suspension to a 15 mL centrifuge tube, centrifuge at 300 × g for 5 minutes, and discard the supernatant.
07. Transfer 5 mL of complete culture medium to resuspend the cells, adjust the seeding ratio as needed, and replenish the culture flask with complete medium—add up to 13–15 mL for a T75 flask or 5 mL for a T25 flask—and supplement with 1% double antibiotic solution.
08. After capping the bottle and tightening the lid, gently shake the vial to ensure uniform mixing of the cells, then place it in a 37°C incubator with 5% CO2.

cell cryopreservation

01. Prepare the cryopreservation solution and pre-cool it in advance.
02. Ensure that the cells to be cryopreserved meet the cryopreservation requirements, and verify the following conditions under a microscope: healthy appearance and morphological characteristics, being in the late logarithmic growth phase, and showing no signs of contamination or senescence.
03. Digest and centrifuge the cells (refer to the subculture protocol for specific steps).
04. Resuspend the cells in cryopreservation medium at 1 mL per tube, gently pipette up and down to ensure uniformity, then aliquot into cryovials.
05. Place the cells in a programmed cooling box and freeze them in a −80°C freezer.
06. Subsequently, the cells are transferred to a liquid nitrogen tank for long-term storage.